Objective: To determine the prevalence of lipodystrophy, dyslipidemia, and hyperglycemia among HIV-infected patients taking long-term, first-line, World Health Organization (WHO)-recommended generic highly active antiretroviral therapy (HAART) regimens in India.
Design: : Cross-sectional study.
Methods: Asymptomatic, antiretroviral-naive patients and those treated for > 1 year with zidovudine (ZDV)/lamivudine (3TC)/nevirapine (NVP) and stavudine (d4T)/3TC/NVP were subjectively assessed for lipodystrophy (lipoatrophy, lipohypertrophy, and mixed patterns), and lipid profiles were determined after an overnight fast. The US National Cholesterol Education Program III guidelines were used to define dyslipidemia (total cholesterol > or = 200 mg/dL, low-density lipoprotein cholesterol > or = 130 mg/dL, triglycerides > or = 150 mg/dL, high-density lipoprotein cholesterol < 40 mg/dL, and total cholesterol/high-density lipoprotein cholesterol ratio > or = 6.5). Prevalence and risk factors associated with these complications were determined.
Results: Of the 306 patients (126 controls, 30 on ZDV/3TC/NVP, and 150 on d4T/3TC/NVP), the prevalence of lipodystrophy was 46.1%, and lipoatrophy was significantly associated with d4T use. The prevalence of dyslipidemia and fasting hyperglycemia was significantly higher in the treatment groups. Proportion of patients with high-density lipoprotein > or = 60 mg/dL was significantly higher in the treatment groups; however, this had little impact on the total cholesterol/high-density lipoprotein ratio.
Conclusion: There is a high prevalence of lipodystrophy, dyslipidemia, and hyperglycemia in patients taking long-term WHO-recommended generic HAART in western India. Interventions to address these complications need to be incorporated into antiretroviral scale-up programs, including improving access to alternative less-offending drugs like tenofovir and abacavir.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Autophagy-dependent hepatocyte secretion of DBI/ACBP induced by glucocorticoids determines the pathogenesis of cushing syndrome.
Autophagy
December 2024
Metabolomics and Cell Biology Platforms, UMS AMMICa, Gustave Roussy Institut, Villejuif, France.
DBI/ACBP is a phylogenetically ancient hormone that stimulates appetite and lipo-anabolism. In response to starvation, DBI/ACBP is secreted through a noncanonical, macroautophagy/autophagy-dependent pathway. The physiological hunger reflex involves starvation-induced secretion of DBI/ACBP from multiple cell types.
View Article and Find Full Text PDFInvolvement of a battery of investigated genes in lipid droplet pathophysiology and associated comorbidities.
Adipocyte
December 2024
Department of Biomedical Sciences, Faculty of Medicine and Medical Sciences, University of Balamand, Kalhat, Lebanon.
Lipid droplets (LDs) are highly specialized energy storage organelles involved in the maintenance of lipid homoeostasis by regulating lipid flux within white adipose tissue (WAT). The physiological function of adipocytes and LDs can be compromised by mutations in several genes, leading to NEFA-induced lipotoxicity, which ultimately manifests as metabolic complications, predominantly in the form of dyslipidemia, ectopic fat accumulation, and insulin resistance. In this review, we delineate the effects of mutations and deficiencies in genes - , , , , , , , , , and - involved in lipid droplet metabolism and their associated pathophysiological impairments, highlighting their roles in the development of lipodystrophies and metabolic dysfunction.
View Article and Find Full Text PDFCorrelation of APOE polymorphism, expression, and plasma levels with cardiac comorbidities among lipodystrophy in HIV-infected patients.
Clin Chim Acta
January 2025
Department of Molecular Biology, National AIDS Research Institute Pune 411026, India. Electronic address:
Article Synopsis
- - The study examined the impact of ApoE gene polymorphisms on HIV-related lipodystrophy (HIVLD) and metabolic abnormalities in 200 HIV-infected patients, revealing that certain genotypes might influence the risk of developing these conditions.
- - Results indicated that ApoE alleles 2 and specific genotypes, like 4/4, were connected to a decreased risk of HIV-1 infection and a lower likelihood of severe HIVLD, whereas allele 2 was linked to increased risk of both HIV acquisition and HIVLD severity.
- - Additionally, the study found correlations between specific ApoE genotypes and impaired cholesterol and glucose levels in patients without HIVLD, highlighting the intricate relationship between genetics and metabolic health in the context
Cardiometabolic risk factors in women: what's sauce for the goose is not sauce for the gander.
Curr Opin Endocrinol Diabetes Obes
August 2024
Medical School, University of Western Australia.
Purpose Of Review: The aim of this review was to discuss cardiometabolic risk factors that affect women.
Recent Findings: Recent calls to action to address cardiometabolic risk factors specific to women relate to increasing evidence of sex-specific differences in patient-related, drug-related, and socio-demographic factors leading to sub-optimal care of women.
Summary: Certain aspects of common modifiable cardiovascular risk factors (e.
Cardiometabolic complications in children and adolescents with HIV on antiretroviral therapy.
Expert Opin Drug Metab Toxicol
September 2024
Department of Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Article Synopsis
- - The introduction of antiretroviral therapy (ART) has greatly improved the lives of individuals with HIV, but it can lead to significant side effects, particularly cardiometabolic complications, especially in children and adolescents.
- - A literature review was conducted to gather current knowledge on metabolic issues (like dyslipidemia and insulin resistance) and diseases (such as prediabetes and cardiovascular diseases) linked to ART in the pediatric population with HIV.
- - Close monitoring of these metabolic complications is crucial as they heighten the risk of developing serious health conditions later in life. Addressing these challenges requires better access to treatments, technology advancements, and a focus on reducing healthcare disparities.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!